Exploration of galectin-3 segments for therapeutic targeting in various diseases, suggesting new treatment approaches.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sindrewicz-Goral et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: